Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Operating Leases (2019 - 2025)

Historic Operating Leases for Medifast (MED) over the last 7 years, with Q4 2025 value amounting to $10.7 million.

  • Medifast's Operating Leases rose 755.31% to $10.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $10.7 million, marking a year-over-year increase of 755.31%. This contributed to the annual value of $10.7 million for FY2025, which is 755.31% up from last year.
  • As of Q4 2025, Medifast's Operating Leases stood at $10.7 million, which was up 755.31% from $12.3 million recorded in Q3 2025.
  • In the past 5 years, Medifast's Operating Leases registered a high of $31.0 million during Q1 2022, and its lowest value of $6.6 million during Q1 2021.
  • In the last 5 years, Medifast's Operating Leases had a median value of $18.4 million in 2024 and averaged $18.8 million.
  • In the last 5 years, Medifast's Operating Leases skyrocketed by 37011.96% in 2022 and then crashed by 3834.56% in 2024.
  • Medifast's Operating Leases (Quarter) stood at $26.0 million in 2021, then dropped by 22.08% to $20.3 million in 2022, then decreased by 20.46% to $16.1 million in 2023, then plummeted by 38.35% to $9.9 million in 2024, then grew by 7.55% to $10.7 million in 2025.
  • Its Operating Leases stands at $10.7 million for Q4 2025, versus $12.3 million for Q3 2025 and $13.1 million for Q2 2025.